comparemela.com

Latest Breaking News On - ஹார்வர்ட் யாத்ரீகர் ஆரோக்கியம் பராமரிப்பு இன்க் - Page 2 : comparemela.com

CDC: Over 500 Deaths Now Following mRNA Experimental Injections – Vaccine Hesitancy Increasing

CDC: Over 500 Deaths Now Following mRNA Experimental Injections – “Vaccine Hesitancy” Increasing by Editor, Health Impact News The CDC has done another data dump into the Vaccine Adverse Event Reporting System (VAERS), a U.S. Government funded database that tracks injuries and deaths caused by vaccines. The data goes through January 29, 2021, with 11,249 recorded adverse events, including 501 deaths following injections of the experimental COVID mRNA shots by Pfizer and Moderna. Besides the recorded 501 deaths, there were 2443 visits to Emergency Room doctors, 156 permanent disabilities, and 1066 hospitalizations. Almost 70% of the recorded deaths were among people over the age of 65. As we have previously reported, because the VAERS reporting system is voluntary, studies show that less than 1% of all vaccine injuries and deaths are recorded.

181 Dead in the U S During 2 Week Period From Experimental COVID Injections – How Long Will We Continue to Allow Mass Murder by Lethal Injection?

181 Dead in the U.S. During 2 Week Period From Experimental COVID Injections – How Long Will We Continue to Allow Mass Murder by Lethal Injection? by Editor, Health Impact News The Vaccine Adverse Event Reporting System (VAERS) is a U.S. Government funded database that tracks injuries and deaths caused by vaccines. A 2011 report by Harvard Pilgrim Health Care, Inc. for the U.S. Department of Health and Human Services (HHS) stated that fewer than one percent of all vaccine adverse events are reported to the government: Although 25% of ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration (FDA).

U S , New Hampshire Sue to Block Merger of Health Insurance Suppliers

Health your username December 15, 2020 The United States and New Hampshire have filed a civil antitrust action in the District of New Hampshire to halt the proposed merger of two commercial health insurance sellers, Harvard Pilgrim Health Care, Inc. and Health Plan Holdings, Inc. Monday’s filing alleges that consolidation will likely harm New Hampshire commercial group health insurance purchasers by raising prices, decreasing quality, and reducing healthcare choices. According to the filing, Harvard Pilgrim has over one million members who subscribe to its commercial group health insurance. Its customers are reportedly small and large employer groups in New Hampshire, Massachusetts, Connecticut, and Maine.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.